Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.
Jose R ArribasEdwin DeJesusJan van LunzenChristine ZurawskiManuela DoroanaWilliam TownerAdriano LazzarinMark NelsonDamian McCollKristen AndreattaRaji SwamyJavier SzwarcbergThai NguyenPublished in: HIV clinical trials (2017)
E/C/F/TDF is a safe, effective long-term alternative to multi-tablet PI + RTV + TVD-based regimens in virologically suppressed, HIV-1-infected adults, and improves patient-reported gastrointestinal symptoms.